Abstract
Introduction: In response to the COVID-19 pandemic, many centres have adopted patent blue single technique for sentinel lymph node biopsy (SLNB) due to logistical challenges of accessing or administering isotope whilst minimising patient exposure to COVID. We aimed to assess the efficacy of blue dye alone in real-world practice, compared to the standard practice of Tenetium99 isotope with or without blue dye.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callSimilar Papers
More From: European Journal of Surgical Oncology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
